Hepatitis C Virus (HCV) NS5B Drug Resistance Assay (LabCorp) Build info

Synonyms

  • HEPATITIS C NS5B DRUG RESISTANCE
  • LAB11835

Short Name

HEPATITIS C NS5B DRUG RESISTANCE

Procedure Master Number

LAB11835

Procedure ID

115911

Clinical Info

Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5B inhibitors. Assay should be used for patients with documented HCV genotype 1.

Specimen Type

Container

Lavender Top Tube

Collection Instructions

Container/Tube:   Two Lavender-top (EDTA) tubes or two PPT™ tubes
Specimen: 2 mL EDTA plasma (1 mL min)
Transport Temperature: Frozen EDTA plasma (PPT™ tubes can be spun and frozen)
Collection : Centrifuge specimen within six hours of collection, remove serum/plasma, and transfer specimen to polypropylene screw-capped tubes, and freeze. Specimens drawn into PPT™ tubes need to be centrifuged within six hours and frozen.
 
 
Special Instructions Please indicate the patient's HCV genotype (1a or 1b) on the test request form
 
 

Transport Instructions

Frozen EDTA plasma (PPT™ tubes can be spun and frozen)

Specimen Stability

Methodology

Polymerase chain reaction (PCR) amplification and DNA next generation sequencing

Days Performed

Performing Laboratory

LabCorp-Monogram Bioscience

CPT

87900
87902
 
TAT: 11- 15 Days

PDM

5908815

Results
Component Name Base Name Common Name External Name
HCV NS5B RESIST INTERP HCVNS5B HCV NS5B RESIST INTERP Hcv Ns5B Resist Interp
HCV NS5B DRUG RESISTANCE HCVNS5B HCV NS5B DRUG RESISTANCE Hcv Ns5B Drug Resistance